Associations - TMB-L - LARVOL VERI

BIOMARKER:

TMB-L

Related biomarkers:

Expression

Mutation

Others

‹

›

TMB-L TMB-L	Melanoma Melanoma	trametinib + dabrafenib + PDR001 Sensitive: B - Late Trials trametinib + dabrafenib + PDR001 Sensitive : B
TMB-L TMB-L	Colorectal Cancer CRC	durvalumab + CP-675206 Sensitive: C3 – Early Trials durvalumab + CP-675206 Sensitive : C3
TMB-L TMB-L	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	mitotane Sensitive: C3 – Early Trials mitotane Sensitive : C3
TMB-L TMB-L	Malignant Pleural Mesothelioma Malignant Pleural Mesothelioma	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3
TMB-L TMB-L	Malignant Pleural Mesothelioma Malignant Pleural Mesothelioma	PD-L1 inhibitor Resistant: C3 – Early Trials PD-L1 inhibitor Resistant : C3
TMB-L TMB-L	Glioblastoma GBM	PD1 inhibitor Sensitive: C3 – Early Trials PD1 inhibitor Sensitive : C3
TMB-L TMB-L	Non Small Cell Lung Cancer NSCLC	atezolizumab Sensitive: C3 – Early Trials atezolizumab Sensitive : C3
TMB-L TMB-L	Non Small Cell Lung Cancer NSCLC	durvalumab + CP-675206 Resistant: C3 – Early Trials durvalumab + CP-675206 Resistant : C3
TMB-L TMB-L	Pancreatic Cancer Pancreatic Cancer	nivolumab + BMS-986227 Sensitive: C3 – Early Trials nivolumab + BMS-986227 Sensitive : C3
TMB-L TMB-L	Lung Cancer Lung Cancer	Tyrosine kinase inhibitor Sensitive: C3 – Early Trials Tyrosine kinase inhibitor Sensitive : C3
TMB-L TMB-L	Gastric Cancer Gastric Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
TMB-L TMB-L	Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma	trametinib + Torin1 Sensitive: D – Preclinical trametinib + Torin1 Sensitive : D
TMB-L TMB-L	Gastric Cancer Gastric Cancer	olaparib Resistant: D – Preclinical olaparib Resistant : D

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

ACCEPT COOKIES

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

ACCEPT COOKIES

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

ACCEPT COOKIES